Patent details

EP1332366 Title: Methods for the Assessment of Cellular Proliferative Disorders

Basic Information

Publication number:
EP1332366
PCT Application Number:
PCT/CA/2001/001512
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019800929
PCT Publication Number:
WO/2002/039117
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Methods for the Assessment of Cellular Proliferative Disorders
French Title of Invention:
Procédés d'évaluation des troubles de la prolifération cellulaire
German Title of Invention:
Verfahren zur Beurteilung von zellulären proliferativen Erkrankungen
SPC Number:

Dates

Filing date:
26/10/2001
Grant date:
30/06/2010
EP Publication Date:
30/06/2010
PCT Publication Date:
16/05/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/08/2003
EP B1 Publication Date:
30/06/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/10/2010
Expiration date:
26/10/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/10/2001
 
 

Name:
Oncolytics Biotech Inc.
Address:
Suite 210, 1167 Kensington Crescent N.W., Calgary, Alberta T2N 1X7, Canada (CA)

Inventor

Name:
COFFEY Matthew, C.
Address:
Canada (CA)

Priority

Priority Number:
246728 P
Priority Date:
09/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/574;
Filing date Document type Number of pages